Quironsalud Madrid
Quironsalud Madrid
Espanha, Madrid
Lucía González Cortijo
25 anos de experiência
Clínica certificada :
| Turquia | Áustria | Espanha | |
| Terapêutica hormonal | de $412 | de $7,000 | de $3,000 |
| Terapia de radiação para o cancro colorretal | de $7,000 | de $12,000 | de $10,000 |
| Terapia com Actínio-225 | de $22,955 | de $55,000 | de $45,000 |
| Quimioterapia para cancro da mama | de $1,200 | de $15,000 | de $3,500 |
| Quimioterapia Intraperitoneal Hipertérmica (HIPEC) | de $22,500 | de $40,000 | de $25,000 |
A Bookimed não adiciona taxas extras aos preços de tratamento de Cancro do ovário. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Cancro do ovário e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Cancro do ovário.
HM Hospitales — este é um grupo de 7 principais clínicas espanholas localizadas em Madri (Espanha).
Especialização — oncologia adulta e pediátrica, neurologia, neurocirurgia, cardiologia e ortopedia.
Em 2018, 5 dos 7 hospitais foram incluídos no TOP das melhores clínicas privadas da Espanha segundo a Organização de Monitoramento de Reputação Médica MERCO.
Anualmente, os cirurgiões do HM realizam mais de 26.000 cirurgias, e cerca de 2.500 pacientes são tratados para câncer.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.
She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.
She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.